3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
26
Carcinoma, Non-Small-Cell Lung
15
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Melanoma
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thoracic Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdomyosarcoma
1
Precancerous Conditions
1
Pneumonia
1
Pleural Effusion, Malignant
1
Interventions
belinostat
2
Fulvestrant
2
sodium thiosulfate
1
pembrolizumab
1
enzalutamide
1
cemiplimab
1
X-Rays
1
Therapeutics
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Midazolam
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunotherapy
1
Imatinib Mesylate
1
Hyperthermic Intraperitoneal Chemotherapy
1
Histamine H2 Antagonists
1
Fluorouracil
1
Famotidine
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Biological Therapy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
X-Rays
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled